New Zealand markets closed

Talis Biomedical Corporation (TLIS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
9.30+0.02 (+0.22%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
76,732
130,191
232,545
138,483
Total cash
76,732
130,191
232,545
138,483
Net receivables
50
308
183
471
Other current assets
901
2,783
3,387
3,106
Total current assets
77,683
133,282
236,115
188,724
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
28,393
47,054
27,427
12,679
Accumulated depreciation
-12,944
-12,822
-3,992
-2,998
Net property, plant and equipment
15,449
34,232
23,435
9,681
Other long-term assets
1,542
1,776
6,278
-
Total non-current assets
16,991
36,008
29,713
9,681
Total assets
94,674
169,290
265,828
198,405
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
1,339
3,768
5,122
4,906
Accrued liabilities
715
989
5,303
6,360
Other current liabilities
-
638
1,080
1,333
Total current liabilities
8,772
12,672
19,106
16,031
Non-current liabilities
Other long-term liabilities
-
-
-
5
Total non-current liabilities
16,786
29,879
12,745
290,945
Total liabilities
25,558
42,551
31,851
306,976
Stockholders' equity
Common stock
3
3
6
0
Retained earnings
-539,961
-477,954
-364,942
-172,906
Total stockholders' equity
69,116
126,739
233,977
-108,571
Total liabilities and stockholders' equity
94,674
169,290
265,828
198,405